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Abstract 9 
Cereal-based baby food production process is expected to have an impact on the initial 10 
level of Fusarium mycotoxins that can contaminate the raw materials. The aim of the 11 
present study was to investigate the changes of some of these toxins during roasting and 12 
the treatment with amylolytic enzymes, usually applied during the production process. 13 
Three different cereal flours contaminated with Fusarium graminearum were 14 
considered (barley, wheat and oat). The results did not show significant changes in the 15 
concentration of any of the studied mycotoxins (up to 5% change in deoxynivalenol 16 
concentration after the enzymes were added). The acetyl-deoxynivalenol also showed 17 
slight modifications as a result of the applied processes, however their statistical 18 
significance was not proved. Zearalenone and T-2 and HT-2 toxins remained almost 19 
unaltered throughout the study.   20 
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1. Introduction 25 
Cereal-based products are one of the most important contributors to human diet. Besides 26 
their energetic value they are also rich in health promoting compounds such as dietary 27 
fiber, antioxidants, B group vitamins and minerals (Gani, SM, FA, & Hameed, 2012). 28 
However, also various residues and contaminants may be contained in cereal products. 29 
One of the predominant risks associated with their consumption is the exposure to 30 
mycotoxins. The major mycotoxins occurring in cereals are Fusarium toxins. They are 31 
responsible for the contamination with deoxynivalenol (DON), nivalenol (NIV), T-2 32 
and HT-2 toxins, zearalenone (ZEN), fumonisins (FBs) in maize and small cereals, 33 
which besides serious consequences on human and animal health, also cause a huge 34 
economic impact for the agriculture sector of many countries (Lee & Ryu, 2017; 35 
Marroquín-Cardona, Johnson, Phillips, & Hayes, 2014).  36 
 food safety issues related to mycotoxins in cereals are the 37 
modified forms. They can be produced by the fungi or be a part of the plant defense 38 
mechanism, which is represented by the activity of plant detoxification enzymes 39 
(Berthiller et al., 2013). Considering their proven bioavailability and toxicity in humans 40 
and animals, their co-occurrence with parental forms can increase the adverse effects 41 
associated to each mycotoxin (De Saeger & van Egmond, 2012). Also, there are several 42 
studies investigating their formation from the perspective of an industrial food 43 
production process Morales, Sanchis, 44 
Ramos, & Marín, 2014). As opposite to the parental forms, the modified mycotoxins are 45 
not regulated by the European Union legislation. Considering the occurrence and 46 
toxicity data, FAO/WHO Joint Expert Committee on Food Additives (JECFA) extended 47 
the provisional maximum tolerable daily intake (PMTDI) from DON to a group of 48 
DON, 3-acetyl-deoxynivalenol (3AcDON) and 15-acetyl-deoxynivalenol (15AcDON), 49 
the information regarding deoxynivalenol-3-glucoside (DON-3-Glc) being insufficient 50 
to consider its inclusion in the group (JECFA/FAO, 2011). European Food Safety 51 
Authority (EFSA) recently assessed the risk to human and animal health related to the 52 
presence of DON, 3AcDON, 15AcDON and DON-3-Glc, estimating the occurring 53 
relative concentrations of the modified forms to the parental form as 10, 15 and 20%, 54 
respectively (Knutsen et al., 2017). Also, the report concludes that although the 55 
European population exposure to DON and its modified forms is below the acute 56 
reference dose (ARfD) of 8µg/kg bw a regular exceedance of the TDI (1µg/kg bw) can 57 
present a potential health concern.  58 
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Infants are the population group which is the most sensitive to mycotoxin exposure. 59 
Moreover, according to EFSA scientific opinion related to the human and animal health 60 
risk associated to the presence of mycotoxins, in the case of ZEN, DON and its 61 
modified forms, 3AcDON, 15AcDON and DON-3-Glc, infants showed the highest 62 
acute and chronic dietary exposure compared to other groups of population (EFSA, 63 
2014; Knutsen et al., 2017). Commonly used cereals for baby food production are oats, 64 
wheat, barley, maize, rye, triticale, sorghum, millet and pseudo-cereals, such as quinoa, 65 
buckwheat and amaranth (Klerks et al., 2019). Besides the already mentioned Fusarium 66 
mycotoxins, cereals were found to contain their modified forms 67 
Gottschalk, Barthel, Engelhardt, Bauer, & Meyer, 2007; Lee & Ryu, 2017; Pleadin et 68 
al., 2013). The maximum levels for Fusarium mycotoxins in cereals and cereal-based 69 
baby food are stipulated by the Commission Regulation No 1881/2006 and its annex: 70 
750 and 200 µg/kg for DON in flour and cereal based baby food, respectively; 75 and 71 
20 µg/kg for ZEN in cereal flour and cereal-based infant food, respectively (European 72
Commission, 2006). Commission Recommendation 165/2013/EU on the presence of T-73 
2 and HT-2 toxin in cereals and cereal products stipulates indicative levels for the sum 74 
of the two toxins at 200, 100, and 50 µg/kg for oats, maize, and other cereals, 75 
respectively as well as 15 µg/kg for cereal-based foods for infants and young children, 76 
(European Commission, 2013).  77 
From the technological perspective, cereal-based baby food production process is 78 
relatively simple, however the safety requirements are more demanding compared to 79 
other production processes in the food industry (European Commission, 2006a). It is 80 
characterized by four main steps: flour roasting, pre-gelatinization and enzymatic 81 
hydrolysis, enzymes inactivation and drying. Considering the raised questions related to 82 
the safety of the enzymes in food products (e.g. allergies), the producers of cereal-based 83 
baby foods are intending to eliminate the amylolytic treatment from the production 84 
process. Nonetheless, no information is available regarding the nutritional 85 
characteristics of a product obtained this way. Thus, the present study will focus on two 86 
production stages: (1) flour roasting and (2) pre-gelatinization and enzymatic hydrolysis 87 
steps. Flour roasting usually takes place at a temperature range between 105°C and 88 
120ºC, with a duration ranging from 20 min to 40 min. This step is important for the 89 
modulation of the organoleptic characteristics of the cereal flour and also improves its 90 
dispersibility in water during the next production step (Fernández-Artigas, Guerra-91 
Hernández, & García-Villanova, 1999). Pre-gelatinization represents the loss of 92 
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crystalline structure of the starch and its swelling, process that makes it available to the 93 
amylolytic enzymes. From the perspective of the possible mitigation effect on 94 
mycotoxin contamination of the abovementioned production steps, there are no studies 95 
specifically dedicated to cereal-based baby food products, however some available 96 
publications deal with the fate of mycotoxins during roasting and enzymatic production 97 
steps in other foodstuffs (e.g. malting, brewing, breadmaking) (Hazel & Patel, 2004; 98 
Lancova et al., 2008; Pietri, Bertuzzi, Agosti, & Donadini, 2010; Vidal et al., 2014). 99 
Yumbe-Guevara, Imoto, & Yoshizawa (2003) studied the thermal degradation of DON, 100 
ZEN and NIV during the roasting of barley kernels and flour. They observed the first 101 
significant effect on the reduction of mycotoxins at 180 ºC treatment, achieving up to 90 102 
and 80% reduction in DON (11 min treatment) and NIV (60 min treatment), 103 
respectively. For ZEN, no significant effect on toxin concentration was observed at 140 104 
and 160ºC, however 60 min at 220ºC were needed to achieve an 85% reduction in 105 
barley flour. With regard to the effect of the enzymatic reactions applied in food106
industry, -amylase was proven to lead to up to 10% increase in DON (Vidal, 107 
Ambrosio, Sanchis, Ramos, & Marín, 2016), result also found by Zachariasova, 108 
Vaclavikova, Lacina, Vaclavik, & Hajslova (2012) during brewing an breadmaking. 109 
This increase was partially explained by the cleavage of DON-3-Glc under the 110 
enzymatic activity in both studies mentioned above, factor to be possibly considered for 111 
the initial contamination of the selected batches of raw materials. For the loss of T2-112 
toxin parallel to increased values for HT2-toxin in grain analysis it is assumed that the 113 
conversion is an enzyme mediated process due to deacetylation of T2-toxin (Maul, 114 
Pielhau, & Koch, 2014). Also, enzymes are suggested to have a potential for mycotoxin 115 
mitigation when part of processing operations, nonetheless it cannot be considered for 116 
dealing with the products that do not comply with the existing regulation  (Karlovsky et 117 
al., 2016). Consequently, various thermal or enzymatic processed may interfere in 118 
different ways with the Fusarium mycotoxin content of a processed grain sample. 119 
The present study aims to identify the impact of roasting and enzymatic hydrolysis 120 
processes on DON, acetylated DON (3- and 15AcDON), DON-3-Glc, ZEN and T-2 and 121 
HT-2 toxins in Fusarium infected cereal flour under typical conditions used in infant 122 
food production. The three most frequently used cereal flours will be used for the 123 
experiment: oats, wheat and barley. The treatment parameters will be set as close as 124 
possible to the ones used during the cereal-based baby food production process. Results 125 
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will help understand the possible changes in mycotoxin concentration during these 126 
production steps considering the compositional differences in the used cereal flours.  127 
 128 
2. Materials and methods 129 
2.1 Chemicals and reagents  130 
All reagent grade mycotoxin standards (DON, 3-Ac-DON, 15-Ac-DON, ZEN, T-2 and 131 
HT-2 toxins) including the unlabeled and the U-[13C]-labelled were purchased from 132 
Romer Lab Diagnostic (Tulln, Austria). Methanol and acetonitrile as well as magnesium 133 
sulfate, formic acid and ammonium formate were bought from Sigma-Aldrich (Merck 134 
KGaA, Darmstadt, Germany). The amylolytic enzymes ( -amylase and 135 
amyloglucosidase) were kindly provided by Hero Spain (Alcantarilla, Spain). Malic 136 
acid and sodium hydroxide were purchased from VWR Chemicals (Radnor, 137 
Pennsilvania, USA); sodium chloride, glucose and sodium potassium tartrate were 138 
bought from Fisher Scientific (Hampton, New Hampshire, USA); sodium azide and 139 
sodium citrate dihydrate were acquired from Scharlab (Sentmenat, Spain). The 3,5-140 
dinitrosalicylic acid (DNS) was bought from Acros Organics (New Jersey, USA), the 141 
citric acid was acquired from PRS Panreac (Barcelona, Spain) and the starch was 142 
purchased from Sigma Aldrich (St. Louis, Missouri, USA).  143 
2.2 Preparation of mycotoxin contaminated flour  144 
 Three different cereal flours were purchased for the experiment from a local 145 
supermarket in Lleida (Spain), namely barley, oat and wheat flour. A part of each was 146 
inoculated with Fusarium graminearum strain (F.46) obtained from the strains 147 
collection of the Food Technology Department of the University of Lleida.  148 
Before inoculation the flours (500 g portions) were put in ISO bottles and sterilized in 149 
an autoclave. Afterwards, the flours were aseptically transferred to Petri dishes and 2 150 
mL of sterile MilliQ water was added to each Petri dish, which were later stored 151 
overnight at 4ºC to achieve a water activity of 0.99 (Aqualab, Serie 3 TE, Decagon 152 
Devices, Washington, USA). Then, 1 mL of spore suspensions of F. graminearum (106 153 
spores/mL) was sprayed on each dish. Petri dishes with barley, wheat and oat flour were 154 
then incubated at 25 °C for 21 days. Afterwards, the contaminated flours were dried at 155 
40 °C, homogenized and DON and ZEN levels were determined.  156 
To obtain the required mycotoxin concentration, the contaminated flour was mixed with 157 
uncontaminated one in certain proportions. For each of the treatments a separate flour 158 
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mix was prepared. Table 1 regroups the initial concentrations of the analyzed 159 
mycotoxins in the three matrices.  160 
2.3 Flour roasting 161 
The roasting of the contaminated flour was performed using a convection oven 162 
(Eurofred, Barcelona, Spain). To confirm that the right temperature was applied 163 
throughout the entire treatment time, a temperature logger (Plug&Track, Progres Plus, 164 
Willems, France) was used inside the oven. For each designed setup (temperature vs 165 
time), 50g of contaminated sample were weighted and placed in aluminum trays 166 
(32x21x5cm) in order to form a very thin layer (approximately 1 cm) to ensure that the 167 
oven temperature is easily reached inside the sample. Two temperature levels were 168 
chosen, namely 105 and 120ºC with a treatment length of 30 and 40 min each. Every 169 
sample was processed in triplicate and collected at the end of the programmed time. A 170 
total of 12 samples of each flour type (barley, wheat and oat) were obtained. The treated 171 
samples were cooled down and stored in a dry place at room temperature until their 172 
analysis.  173 
2.4 Enzymatic treatment 174 
Before proceeding to the enzymatic treatment of the cereal flour, it was roasted at 105ºC 175 
for 30 min. Then, the obtained roasted flour was cooled and 30g samples were prepared 176 
by mixing a respective amount of the contaminated flour with the roasted blank flour. 177 
The mix was placed in a 100 mL beaker and the enzymes (a-amylase and glucoamylase) 178 
were added. The available information of the used doses in cereal-based baby food 179 
production process is scarce and non-specific, thus it was decided to add the chosen 180 
enzymes simultaneously at the same dose in each sample: each of the enzymes was 181 
added in two dosages to the samples: 2.1 and 4 g of enzyme/kg of cereal flour. The 182 
53ºC temperature was chosen for the present study as it corresponds to the temperature 183 
allowing the activity of both enzymes. Once the flour and enzyme mix was ready, 70 184 
mL of distilled water at 53ºC was added and the slur was put into a water bath for 10, 185 
50 and 90 min. Samples for each treatment were prepared in parallel and per triplicate 186 
for every designed setup. When the time expired, the samples were rapidly cooled in an 187 
ice bath, frozen and lyophilized (Telstar LyoBeta 15, Terrassa, Spain). The obtained 188 
lyophilized samples were then packed individually and stored in a dry place at room 189 
temperature until analysis.  190 
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2.5 Assessment of the enzymatic activity  191 
The activity of the added -amylase and glucoamylase was quantified throughout the 192 
experiment to evaluate if there were differences in starch hydrolysis related to each 193 
studied matrix. 194 
2.5.1 -amylase activity 195 
The activity of the -amylase used during the experiment was determined according to 196 
Vidal et al. (2016). Briefly, 1.5 g of treated flour was weighted in 12 mL polypropylene 197 
tubes and 10 mL of extraction solvent (0.2M malic acid:0.35M sodium hydroxide:0.2M 198 
sodium chloride:0.003M sodium azide, 1:1:1:1, v/v/v/v) was added. The obtained mix 199 
was incubated in a water bath for 20 min at 40ºC. Then, 0.5 mL of the supernatant was 200 
mixed with 1.5 mL substrate (1g of starch in 20 mL of 1M sodium hydroxide, 10 mL of 201 
1.06M sodium and potassium tartrate and 70 mL water). It was left to interact for 3 min 202 
at 25ºC, followed by the addition of 1 mL of DNS reagent (1g of DNS, 20 mL of 2M 203 
sodium hydroxide, 10 mL of 1.06 M sodium and potassium tartrate and 70 mL water) 204 
and boiled in a water bath for 5 min. The whole mix was cooled down in a cold-water 205 
bath and 10 mL of distilled water were added. The absorbance of the obtained solution 206 
was measured in an UV-visible spectrophotometer (Helios , Thermo Electron 207 
Corporation, Waltham, Massachusetts, USA) at a wavelength of 540 nm. The results 208 
were compared to a glucose standard curve with concentrations ranging from 1 to 10 209 
mg of glucose/mL (r2=0.99). The corresponding dilution factor was applied to the 210 
analysed samples.   211 
2.5.2 Glucoamylase activity 212 
Glucoamylase activity in all the samples was evaluated according to the method 213 
described by Puri et al. (2013). The enzymatic activity was expressed in international 214 
units (IU), one IU being defined as µmol of glucose per min and milliliter under the 215 
standard assay conditions using a glucose standard curve. Briefly, 1g of treated flour 216 
was added to 10 mL of 0.1M citrate buffer (pH=5) and stirred at 250 rpm for 30 min. 217 
Then, the mix was centrifuged at 5000 rpm for 20 min (Hettlich Universal 320R, 218 
Tuttlingen, Germany) and 1 mL of supernatant was mixed with 1mL of 1% maltose in 219 
0.1M citrate buffer (pH=5). The obtained extract was then incubated in a water bath for 220 
30 min at 45ºC. The reaction was stopped by adding 3 mL of DNS reagent (composition 221 
described above) and submitted to a boiling water bath for 15 min. One mL of 40% 222 
solution of sodium potassium tartrate and 1 mL of distilled water were added prior to 223 
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cooling the extract to room temperature. Afterwards, absorbance was measured at 575 224 
nm using an UV-visible spectrophotometer and the results were compared to a standard 225 
curve using glucose at concentrations between 1 to 10 mg of glucose/mL (r2=0.99), 226 
applying the appropriate dilution factor. 227 
2.6 Mycotoxin extraction, detection and quantification 228 
2.6.1 Sample preparation 229 
The sample preparation method is based on the draft WI 00275287 of the pre-norm 230 
FprN 17279 (DIN, 2018), describing a LC-MS/MS screening method developed under 231 
CEN/TC 275/WG5. Briefly, 5g of sample were weighted in a 50 mL polypropylene 232 
tube, mixed with 20 mL acetonitrile/water (50:50, v/v), shaken for 30 min (Multi Reax, 233 
Heidolph Instruments GmbH & Co.KG, Schwabach) and centrifuged for 30 min at 4500 234 
rpm (Microfuge R, Beckman Coulter, Brea, California, USA). Then, 1 mL of the 235 
supernatant was taken and mixed with 100 µL of the internal standard solution and 236 
100µL of MiliQ water. Afterwards, 250 mg of anhydrous magnesium sulfate was 237 
added, vortexed for another 30 seconds, centrifuged for 5 min at 14000 rpm (Microfuge 238 
R, Beckmann, Krefeld, Germany) and 200 µL of supernatant were diluted with 400 µL 239 
water and submitted to HPLC-MS/MS analysis.  240 
In order to minimize the losses of the more hydrosoluble analytes during phase 241 
separation step, the sample preparation before injection for the initial screening of the 242 
mycotoxins followed only the first four steps of the protocol described above, namely 243 
mixing the 5g of sample with 10 mL water and 10 mL acetonitrile, followed by shaking, 244 
centrifuging and taking 1 mL of the supernatant for injection into the LC-MS/MS. 245 
2.6.2 LC-MS/MS analysis 246 
A Shimadzu Nexera X2 HPLC system equipped with a binary pump and a thermostatic 247 
autosampler (Kyoto, Japan), coupled with a triple quadrupole mass spectrometer 248 
QTRAP 6500+ (SCIEX, Framingham, Massachusetts, USA) were used. Data 249 
acquisition and processing was achieved using Analyst® and MultiQuant® software 250 
(SCIEX, Framingham, Massachusetts, USA). Separation was achieved on Restek 251 
Raptor Fluoro phenyl 100x2.1 mm, 5µm column (Bellefonte, Pennsylvania, USA).  252 
The mobile phase consisted of water (A) and methanol (B), both containing 0,1% 253 
formic acid and 300 mg/L ammonium formate, which was supplied at a gradient with a 254 
flow rate of 0.5 mL/min. The initial gradient was kept at 2% B for 0.8 min, after 4 min 255 
B was increased to 53%, after 6 min B was set at 60%, after 11 min B was 95%, 256 
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followed by 1.5 min washout at 95% B and a 5 min equilibration period at the initial 257 
conditions. Total run time was 17.5 min.  258 
The detector was operated in both positive and negative electrospray ionization (ESI) 259 
modes under multiple reaction monitoring (MRM). Operating ESI conditions were 260 
setup as follows: curtain gas: 40 psi, gas 1: 60 psi, gas 2: 35 psi, collision gas flow: 261 
medium and source temperature: 300 °C. Ion spray voltage (IS) was set at 4500 V and -262 
4000 V in positive and negative ionization mode respectively.  Two characteristic ions 263 
were chosen for the assessment of the mycotoxins in the samples for quantification and 264 
for qualitative confirmation of the analytes. To compensate for matrix effect, stable 265 
isotope dilution assay was performed using U-[13C]-labelled mycotoxins. Internal 266 
standard concentrations were 35.6 ng/mL for DON, 34.3 ng/mL for ZEN, 8.6 ng/mL for 267 
3-AcDON, 4.3 ng/mL for 15-AcDON, 2.9 ng/mL for T2 and 2.9 ng/mL for HT2 in the 268 
final sample submitted to LC-MS analysis. The recovery rate for DON, ZEN, AcDON, 269 
T2 and HT2 toxin was determined by tenfold spiking and analysis of blank oat samples. 270
The intraday precision calculated from these spiked samples was ranging from 2.5 % 271 
for DON up to 12.7 % for 15-AcDON. Table 2 additionally regroups the data 272 
concerning the selected ion transitions, the parameters of the mass detector specific for 273 
each fragment ion as well as the individual recoveries and limits of detection (LOD) and 274 
quantification (LOQ). LOD was determined by spiking blank samples and the LOQ was 275 
derived from it according to Wenzl, Haedrich, Schaechtele, Robouch, & Stroka (2016). 276 
Rather high spiking levels of T-2 and HT-2 toxins compared to the levels found in the 277 
samples led to obtention of higher than expected LOD and subsequently LOQ for both 278 
analytes; however, semi-quantitative results are shown.  279 
2.7 Data Evaluation 280 
MultiQuant  software (SCIEX, Framingham, Massachusetts, USA) was used for the 281 
LC-MS/MS data handling and evaluation of the analyzed samples. ANOVA analysis 282 
was applied to the obtained results to determine the significance (p=0.05) of the 283 
observed changes.  284 
3. Results and discussion 285 
3.1 Initial screening of mycotoxins  286 
Barley, wheat and oat flours used in the present study were intentionally contaminated 287 
with a Fusarium graminearum strain, mainly producing DON and ZEN. Reports also 288 
suggested the ability of F. graminearum strains of producing some of their modified 289 
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forms, such as 3-Ac-DON, 15-Ac-DON, -zearalenol ( -ZEL), -zearalenol ( -ZEL) 290 
and others (Hagler, Mirocha, Pathre, & Behrens, 1979; Mirocha, Abbas, Windels, & 291 
Xie, 1989). Besides the abovementio  and their modified 292 
forms, the study seeks to evaluate the , 293 
such as enniatins, beauvericin, sterigmatocystin, which might occur in high frequency 294 
or high concentration in cereals and cereal products originating from a natural field 295 
contamination (Gruber-Dorninger, Novak, Nagl, & Berthiller, 2017).  296 
To achieve this aim and decide on the mycotoxins that, additional to DON and ZEN, 297 
should be focused on in this study, an initial screening of mycotoxins was performed on 298 
two groups of samples for each matrix (barley, wheat and oat): (i) samples before 299 
treatment and (ii) samples treated with a dosage of 4.0 g of enzyme/kg of flour, during 300 
90 min. This screening was also aiming to search for the presence of DON-3-Glc, 301 
previously reported as being formed as a result of plant enzymatic activity (Ronald 302 
Maul et al., 2012; Vidal et al., 2016).  303 
The initial screening omitting the phase separation step that would discriminate the 304 
most polar compounds led to the identification of the presence of several emerging 305 
mycotoxins, mainly produced by Fusarium species. The mycotoxins found in all the 306 
samples were DON, 3-Ac-DON, 15-Ac-DON, and ZEN. T-2 and HT-2 toxins were 307 
only found in oat flour, both before and after the enzymatic treatment. In the case of the 308 
B) was present in all the samples, however it 309 
showed a relatively low signal intensity. Beauvericin (BEA) was found in barley and 310 
oat samples but not in wheat. Sterigmatocystin and enniatin B1 (ENN B1) were only 311 
present in oat samples, however also in very low amounts. The findings of the initial 312 
screening of mycotoxins were in accordance to the occurrence studies available 313 
et al., 2016; Lindblad et al., 2013; Santini, Meca, Uhlig, & Ritieni, 2012).  314 
At the end of the present screening, it could be seen that the analyzed samples presented 315 
316 
brought the work to the need of focusing the study to the quantification of the most 317 
abundant following analytes: DON, 3-and 15-AcDON, ZEN and, in the case of oat 318 
flour, T-2 and HT-2 toxins were included, but the data need to be considered as only 319 
semi-quantitative due to their low content levels.  320 
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3.2 Roasting  321 
In food processing, roasting is an important step in flavor modulation and enhancement 322 
through caramelization and Maillard reactions taking place on the surface of the 323 
product. Besides, cereal roasting is one of the processes thought as potentially being 324 
able to reduce the initial mycotoxin charge. Table 1 regroups the initial concentration of 325 
mycotoxins in the prepared contaminated flours which were submitted to roasting. 326 
Figure 1 shows the changes in mycotoxin concentration in the three flours after 327 
applying each combination of time and temperature. 328 
For DON, no significant change in concentration was observed in none of the three 329 
matrices studied. Although in barley the effect of the treatment was more pronounced at 330 
105ºC after 30 and 40 min roasting (p=0.05), the observed trend is not aligned with the 331 
one in wheat and oat flours (no significant change in the level of mycotoxin). Similarly, 332 
no change of DON content during roasting was reported several times (Milani & 333 
Maleki, 2014; Yumbe-Guevara et al., 2003), showing that at least a heat treatment of 334 
160ºC for 15 min is needed in order to achieve a reduction of 10% in bread and biscuits 335 
baking. However, Kaushik (2015) in its review reported studies showing no effect of 336 
baking in breadmaking process on DON concentration nor after 30 min at 170ºC, nor 337 
after 30 min at 205ºC.  338 
There are many recent studies investigating the fate of DON during food processing 339 
(Malachova et al., 2010; Pronyk, Cenkowski, & Abramson, 2006; Vidal et al., 2014), 340 
however regardless its frequent co-occurrence with 3-AcDON and 15-AcDON, studies 341 
on the alteration of these DON conjugates contents are scarce (Wu & Wang, 2016). In 342 
the present work, 15-AcDON was present in the three matrices, however 3-AcDON 343 
(Fig. 2a) was present only in barley, probably due to small differences in toxin 344 
production of the fungus used for flour treatment related to individual matrix 345 
composition of barley, wheat and oat (Mirocha et al., 1989). 3-AcDON showed a very 346 
similar trend of a slight toxin level decrease like DON in barley (reduction of the level 347 
of the toxin after 30 min at 105ºC and its increase after 40 min at the same temperature), 348 
which can be explained by its conversion into the parent compound. Nonetheless, the 349 
low absolute amounts of 3-AcDON compared to DON and its presence exclusive for 350 
treated barley flour cannot doubtlessly confirm this assumption. No significant 351 
differences related to the applied treatment are observed for 15-AcDON in any of the 352 
flours.  353 
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ZEN shows a decreasing tendency during the roasting process at both temperatures, 354 
however none of the changes in concentration were significant. This matches the 355 
previous studies investigating ZEN thermal stability during roasting, which had proven 356 
its high resistance to temperature treatment (Kabak, 2009; Yumbe-Guevara et al., 2003).  357 
Besides the F. graminearum toxins coming from the intended contamination in the 358 
laboratory, the analysis of the oat flour identified the presence of T-2 and HT-2 toxins. 359 
Due to the low levels identified, the derived content data have to be considered as a 360 
semi-quantitative assessment. The toxins were proven as relatively stable with only 361 
slight changes compared to the initial level found before the treatment was applied. The 362 
result shows more stability compared to the study performed by Kuchenbuch, Becker, 363 
Schulz, Cramer, & Humpf (2018), where the decrease of the toxins during roasting 364 
represented approximately 5%, however their experiment included two previous 365 
operations which led to the main decrease in both toxins. Perhaps, an intended 366 
contamination with these toxins could help better explain their fate during roasting. 367
Despite the expected effect of the relatively long treatment time compensating for the 368 
low roasting temperature from the perspective of mycotoxins reduction, no significant 369 
impact of the roasting process on mycotoxin levels was observed.  370 
Additionally, no significant correlation between different mycotoxins was recorded.  371 
3.3  Enzymatic treatment 372 
There are no studies available on the impact of enzymatic processes on Fusarium 373 
mycotoxin levels during baby food production process, however enzymes are also 374 
commonly used in food production processes either with the aim of achieving the 375 
specific characteristics of the final product (e.g. brewing) or for the improvement of the 376 
technological quality and shelf life (e.g. breadmaking, production of fruit juice) 377 
(Juodeikiene, Basinskiene, Vidmantiene, & Bartkiene, 2009; Kostelanska et al., 2011; 378 
Malachova et al., 2011; Vidal et al., 2016). 379 
Two enzymes were used in the present study ( -amylase and glucoamylase) at two 380 
doses (2.1 and 4.0 g of enzyme/kg of flour). According to the usual conditions of such 381 
enzymatic treatments the first samples have been taken after homogeneous slurry has 382 
been obtained, i.e. after 10 min of incubation with the enzymes. Table 3 regroups the 383 
information on the units of glucose per minute transformed as a result of the presence of 384 
the amylolytic enzymes in 1 g of flour. It can be seen that the activity changes 385 
depending on the matrix used, which is probably related to the differences in the 386 
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structure of the starch in the different cereals which has implications on the efficacy of 387 
the reaction (Gupta, Gigras, Mohapatra, Goswami, & Chauhan, 2003).  388 
Figure 3 illustrates the changes in concentration of DON, 15-AcDON and ZEN during 389 
enzymatic hydrolysis caused by two amylolytic enzymes in barley, wheat and oat 390 
flours. The obtained results indicate a relatively unchangeable levels of DON in the 391 
three matrices (barley, wheat and oat) and even a slight decrease when 2.1 g of 392 
enzyme/kg flour was added (between 1.5 and 4%), however it is not proved statistically 393 
significant. One similar study of Vidal et al. (2016) reports on the increase in DON (up 394 
to 10%) due to -amylase activity, mainly as a result of their release from the cereal 395 
matrix, however the temperature used for bread fermentation was 30 and 45ºC, which 396 
could have been the reason of the different result obtained.  397 
In the case of 15-AcDON, which was found in all of the three studied flours, a deviating 398 
behavior during the process was observed, manifesting a slight increasing trend in 399 
barley flour and decreasing in wheat and oat flour. For barley flour, the tendency was 400 
more pronounced at a higher enzyme concentration. Wheat flour was characterized by a 401 
higher and clear decrease of 15-AcDON at 2.1 g of enzyme/kg flour dose compared to 402 
the 4.0 g/kg after 90 min treatment. In the oat flour, a trend of 15-AcDON decrease over 403 
time similar to wheat flour was registered, however at a much smaller extent. 3-AcDON 404 
which was found only in barley flour, was following a very similar trend to its isomer 405 
15-AcDON during the enzymatic treatment (Fig. 2b). There are no available studies 406 
focusing on these modified forms of DON which the present work could relate to in 407 
order to explain the observed, although small, changes in concentration during the 408 
enzymatic process applied.  409 
ZEN content remained almost unchanged throughout the whole process at both doses of 410 
the enzymes applied in barley, wheat and oat flours. However, the high level of ZEN 411 
present in the flour samples might prevent the detection of small absolute alterations 412 
throughout the processes. Thus, more studies are needed in order to identify more 413 
certainly the behavior of the toxin during enzymatic processes in food industry.  414 
T-2 and HT-2 toxin contents in oat did not undergo any significant change at none of 415 
the two applied doses of enzymes (Figure 4). Also, their identified low levels were of no 416 
concern from the safety perspective investigated by the present study. There are no 417 
available studies showing a possible effect of a treatment with amylolytic enzymes on 418 
the levels of these toxins and no release from the matrix could be observed in the 419 
present study. Other enzymes (such as esterase) are however proven to have the ability 420 
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of converting T-2 toxin into HT-2 toxin (Lattanzio, Visconti, Haidukowski, & Pascale, 421 
2012).  422 
A confirmatory small-scale experiment repeating the enzymatic treatment at 4.0 g 423 
enzyme/kg flour and 90 min incubation time was performed in the three studied flours 424 
(Table 4). All the results obtained before were confirmed and the same tendencies were 425 
shown but for DON, which exhibited an increase of approximately 4.5 and 10% in 426 
wheat and barley, respectively, nonetheless its concentration in oat flour remained 427 
stable after the applied treatment. In general, the obtained data goes in line with an 428 
already published report on DON and its 3-glucoside (Simsek, Burgess, Whitney, Gu, & 429 
Qian, 2012).  430 
4. Conclusion 431 
Cereal based baby food products are an important part of the diet for a very sensitive 432 
group of population. The safety of these products is a priority for the food industry, 433 
especially regarding their contamination with mycotoxins. The present study 434 
investigated the change of concentration of Fusarium mycotoxins during two steps of 435 
the production process: flour roasting and treatment with amylolytic enzymes 436 
(glucoamylase and -amylase).  437 
Roasting did not have any significant impact on none of the analyzed mycotoxins, most 438 
probably due to the relatively low temperatures applied during the process. It is 439 
important to mention also the stability of the acetylated forms of DON, which were still 440 
present in the flours after the treatment was applied. Thus, also in treated infant food 441 
samples conventional analytical methods do not cover this additional source of toxic 442 
potential as acetylated DON remains modified and does not add to DON following 443 
deacetylation. The 15-AcDON showed a slight increase in barley flour and a relatively 444 
small decrease in oat and wheat flours, however these changes could not be confirmed 445 
after the statistical evaluation of the data. ZEN remained stable throughout both 446 
treatments applied. The repeated small-scale enzymatic treatment (using the highest 447 
enzyme amount and the longest treatment time) only confirmed and strengthened the 448 
obtained results.  449 
In summary, it can be concluded that the cereal based baby food production process 450 
does not lead to a significant decrease of Fusarium mycotoxins during the studied steps. 451 
Also, no conversion of the acetylated DON into DON was observed. More extreme 452 
physical parameters could enhance the impact on the studied mycotoxins, however the 453 
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applicability of the new conditions from the technological (i.e. cost, yield, organoleptic 454 
properties) and safety perspectives (i.e. acrylamide formation) should be considered 455 
first. However, also no additional toxin amounts were deliberated from naturally 456 
contaminated matrix due to the applied techniques. This results in the need of a 457 
particularly careful evaluation of the quality of the raw materials with regards to 458 
mycotoxin contamination, especially considering that there are more strict requirements 459 
in the legislation (EC 1881/2006) concerning the maximum levels for mycotoxins in 460 
cereal-based infant food as compared to cereals intended for human consumption.  461 
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Figure 1: Concentrations of deoxynivalenol (DON), 15-acetyl-deoxynivalenol (15-Ac-DON) and zearalenone (ZEN) (±SD) in barley (a), wheat 

























































































Figure 2: Changes in 3-acetyl-deoxynivalenol (3-Ac-DON) concentration (±SD) during barley roasting at 105 and 120ºC for 30 and 40 min (a) 























 Figure 3: Concentrations (±SD) of deoxynivalenol (DON), 15-acetyl-deoxynivalenol (15-Ac-DON) and zearalenone (ZEN) in barley (a), wheat 




(b) and oat (c) during enzymatic treatment ( -amylase and glucoamylase) at a dose of 2.1 and 4.0 g/kg during 10, 50 and 90 min.  
Figure 4: Concentrations of T-2 and HT-2 toxins in oat during enzymatic treatment at a dose 
of 2.1 and 4.0 g/kg during 10, 50 and 90 min. HT-2 toxin evaluated referring to LOD.  
 
Figure 4
Table 1: Initial mycotoxin concentrations obtained in barley, wheat and oat flour 
Matrix Mean concentration, µg/kg SD DON DON-3-Glc 3AcDON 15AcDON ZEN T-2 toxin HT-2 toxin  
Barley 4610 180 n.d. 83.5 6.2 201 14.7 2991 593 n.d. n.d. 
Wheat 1254 100 n.d. n.d. 150 12 1209 152 n.d. n.d. 
Oat 1390 72 n.d. n.d. 482 13.3 5027 219 1.4 0.07 3.85 0.29 




Table 2: Acquisition parameters used for the targeted analytes and recovery rates calculated from the analysis of spiked blank oat flour. 
DON=deoxynivalenol; 3-Ac-DON=3-acetyl-deoxynivalenol; 15-Ac-DON=15-acetyl-deoxynivalenol; ZEN=zearalenone; 1Electrospray 
ionization;  
LOD= limit of detection; LOQ=limit of quantification 
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100.2 95.0 3.3 10.8 





92.2 91.7 1.1 3.5 





100.0 97.2 1.0 3.3 





100.0 111.6 11 36.3 
Table 2
Table 3: Activity of -amylase and glucoamylase in barley, wheat and oat flours after 
each sampling step during enzymatic treatment.   
 
a dose of enzyme added to the flour for the treatment 2.1 and 4.0 g of enzyme/kg of 
flour. 















Sample treatment  Enzymatic activity, mg glucose/g sample*min 
-amylase Glucoamylase 
Barley 2.1 g/kga 4.0 g/kg 2.1 g/kg 4.0 g/kg 
10 min NDb ND 0.26 0.01 0.29 0.01 
50 min ND 0.05 0.007 0.21 0.02 0.18 0.03 
90 min 0.03 0.003 0.14 0.19 0.01 0.19 0.01 
Wheat      
10 min 0.79 0.06 1.11 0.05 0.2 0.01 0.22 0.01 
50 min 1.07 0.04 1.22 0.07 0.23 0.01 0.24 0.01 
90 min 1.28 0.09 1.42 0.1 0.23 0.01 0.21 0.02 
Oat     
10 min 3.55 0.38 1.16 0.1 0.007 0.09 
50 min 4.54 0.25 0.88 0.1 0.11 0.01 0.10 0.01 
90 min 5.06 0.04 0.76 0.07 0.12 0.01 0.1 0.01 
Table 3
Table 4: Mycotoxin concentration after repeating the enzymatic treatment (4.0 g 
enzyme/kg flour, 90 min) 
 
a B.T. = before treatment; b E.T. = enzymatic treatment applied; LOD = Limit of 








Concentration, µg/kg SD 
Barley Wheat Oat 
Deoxynivalenol B.T.a 4728 1225 911 
E.T.b 5217 101 1280 26.5 920 68 
3-Acetyl-
deoxynivalenol 
B.T. 84.7 <LOD 79.2 
E.T. 98.8 2,4 <LOD 76.6 5.4 
15-Acetyl-
deoxynivalenol 
B.T. 179 178 237 
E.T. 209 34 77 16.1 233 33 
Zearalenone B.T. 1606 1380 1931 
E.T. 2151 141 1329 79 2087 271 
HT-2 toxin B.T. <LOD <LOD <LOD 
E.T. <LOD <LOD <LOD 
T-2 toxin* B.T. <LOD <LOD 2.03 
E.T. <LOD <LOD 1.8 0.2 
Table 4
